RX Profiler: Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer
It is exciting to see that patients with advanced breast cancer are able to receive additional treatment options, because a primary concern of patients with stage IV breast cancer is a lack of awareness of laboratory and clinical research targeted for those battling advanced disease.
Based on the prevalence of invasive breast cancer, the amount of drug therapy required among a managed patient population is considerable, and significantly affects the top cancer trend therapies within the cancer budget for payers.
At the Markey Cancer Center in Lexington, KY, clinical pharmacists are integral members of the multidisciplinary care team, working in the clinic alongside surgical and medical oncologists, imaging specialists, radiation oncologists, pathologists, nurses, and other healthcare providers.
Results 1 - 3 of 3